Infinimmune

About

Infinimmune operates as a biotechnology company.

San Francisco,California,United States
1 - 10
https://www.infinimmune.com/

Highlights

Details

Last Funding Type: Seed
Last Funding Money Raised: $12M
Industries: Biotechnology,Health Care,Life Science,Medical
Founded date: Jan 1, 2022
Number Of Employee: 1 - 10
Operating Status: Active

Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$12M

Infinimmune has raised a total of $12M in funding over 2 rounds. Their latest funding was raised on Dec 6, 2022 from a Seed round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 6, 2022	Seed	$12M	9	Playground Global	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

9

Infinimmune is funded by 9 investors. Playground Global and Axial VC are the most recent investors.

Investor Name	Lead Investor	Funding Round
Playground Global	Yes	Seed
Axial VC	—	Seed
Benjamin Kim	—	Seed
Civilization Ventures	—	Seed
Jacob Becraft	—	Seed
Joshua Meier	—	Seed
Paul Conley	—	Seed
Pear VC	—	Seed
Ron Alfa	—	Seed